ClinicalTrials.gov
Hide glossary Study record managers: ref er to the Data Element Definitions if submitting registration or results information.
Hide glossary Study record managers: ref er to the Data Element Definitions if submitting registration or results information.
Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Patients achieving M
Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Patients achieving M
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Drs. Lonial, Nabhan, and Stewart discussed the plenary session at ASH 2023, the PERSEUS trial, and treating smoldering MM.
The 2/20/20 International Myeloma Working Group (IMWG) score is the most employed risk score in clinical practice to evaluate the risk of progression from smoldering…
Research To Practice requires users to log in to view educational content. All content is available without
Allá por el principio de los dos mil escribí una carta a El País Semanal. Relataba en unas pocas líneas, no sin cierta amargura, la…
In patients with immune thrombotic thrombocytopenic purpura (iTTP), autoantibodies against the metalloprotease ADAMTS13 lead to catastrophic microvascular thrombosis. However, the potential benefit…